NANDROLONE DECANOATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for nandrolone decanoate and what is the scope of freedom to operate?

Nandrolone decanoate is the generic ingredient in two branded drugs marketed by Woodward Specl, Abraxis Pharm, Am Regent, Epic Pharma Llc, and Watson Labs, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for nandrolone decanoate.

Summary for NANDROLONE DECANOATE

US Patents:	0
Tradenames:	2
Applicants:	5
NDAs:	11
Drug Master File Entries:	6
Raw Ingredient (Bulk) Api Vendors:	61
Clinical Trials:	11
Patent Applications:	2,035
DailyMed Link:	NANDROLONE DECANOATE at DailyMed

Recent Clinical Trials for NANDROLONE DECANOATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland	Phase 2
Medical Research Agency, Poland	Phase 2
King Edward Medical University	N/A

See all NANDROLONE DECANOATE clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for NANDROLONE DECANOATE

A14AB	Estren derivatives
A14A	ANABOLIC STEROIDS
A14	ANABOLIC AGENTS FOR SYSTEMIC USE
A	Alimentary tract and metabolism

S01XA	Other ophthalmologicals
S01X	OTHER OPHTHALMOLOGICALS
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for NANDROLONE DECANOATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	NANDROLONE DECANOATE	nandrolone decanoate	INJECTABLE;INJECTION	086598-001	Jan 13, 1984		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abraxis Pharm	NANDROLONE DECANOATE	nandrolone decanoate	INJECTABLE;INJECTION	088290-001	Oct 3, 1983		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	NANDROLONE DECANOATE	nandrolone decanoate	INJECTABLE;INJECTION	088128-001	Dec 5, 1983		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.